Pao Group logo

Pao Group(OTC) PAOG

Market Cap$382.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-100%
5 Year-96%
1 Year+100%
1 Month-33%
$0.00
-33.33%
-0.00Today
Pao Group last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-08
Pao Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+100%USD 0.002026-10-01
1 month-33.33%USD 0.002026-09-04
3 month-33.33%USD 0.002026-07-10
Year to date-71.43%USD 0.002025-12-31
1 year+100%USD 0.002025-10-08
3 year+0%USD 0.002023-10-09
5 year-95.83%USD 0.002021-10-08
Since inception-100%USD 760.872007-06-15

Pao Group Financials at a Glance

Market Cap

$382.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$98.55K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

14.24 (High)

Price

$0.00

Volume

6,278,700

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

PAOG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pao Group

PAO Group, Inc. is a healthcare company based in Sandusky, Ohio, specializing in alternative patient care solutions. The company focuses on the development, distribution, and sale of high-quality medicinal cannabis products aimed at supporting individuals with chronic and terminal conditions.

Products and Services
  • Medicinal cannabis products for chronic conditions
  • Alternative patient care solutions through subsidiaries
  • Research and development in healthcare innovations
Growth Outlook
  • Expansion in the medicinal cannabis market is anticipated
  • Increased demand for alternative healthcare solutions is expected
  • Strategic partnerships may enhance product distribution
Financial Highlights
  • Recent quarterly net income of -$13,292 indicates ongoing operational challenges
  • Trailing twelve months show a significant negative return on assets at -469.29%
  • Current liabilities exceed total assets, highlighting financial strain
PAO Group, Inc. operates in a niche market with potential for growth, particularly in the medicinal cannabis sector. The company’s focus on alternative patient care solutions positions it well to meet the increasing demand for innovative healthcare products. However, recent financial data indicates challenges, including negative net income and a high debt ratio, which may impact future operations. Investors may find the company's strategic direction and market potential worth monitoring as it navigates these financial hurdles.
AI Generated • Sep 28, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

James Schramm

Website

www.pao.group

Headquarters

Sandusky, OH 44870, US

PAOG Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

8.34%

Return on Capital

N/A

Return on Assets

-46928.57%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$382.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.91B

Volume

6.28M

Avg. Volume

1.61M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$51.67K

EBITDA

-$51.67K

Operating Cash Flow

$170.14K

Capital Expenditure

$0.00

Free Cash Flow

$170.14K

Cash & ST Invst.

$210.00

Total Debt

$639.95K

Pao Group Performance Analysis

Pao Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Pao Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
Pao Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00-50.0%
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.00N/A
20252025-12-31USD 0.00N/A
Pao Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$382.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$54.57K

N/A

Employees

7

N/A

Net Income

-$13.29K

+55.0%

EBITDA

-$1.61K

+90.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$210.00

-63.5%

Total Debt

$639.95K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$639.95K

+0.0%

Return on Assets

-469.29%

N/A

Return on Invested Capital

4.26%

N/A

Free Cash Flow

-$459.00

+89.2%

Operating Cash Flow

-$459.00

+89.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LCDXCaliber Imaging & Diagnostics, Inc.
$0.00+500.00%
ONSSOnassis Holdings Corp.
$0.00+0.00%
ANTHAnthera Pharmaceuticals, Inc.
$0.00+35.00%
BBLNFBabylon Holdings Limited
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.79+10.24%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$142.52-10.31%
TQQQProShares Trust - ProShares UltraPro Qqq
$80.23-4.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$33.37+4.05%

Questions About PAOG

What is the current price of Pao Group?

Pao Group is trading at $0.00 per share.

What is the 52-week range for Pao Group?

Over the past 52 weeks, Pao Group has traded between $0.00 and $0.00.

How much debt does Pao Group have?

As of the most recent reporting period, Pao Group reported total debt of $639.95K.

How much cash does Pao Group have on hand?

Pao Group reported $210.00 in cash and cash equivalents in its most recent financial results.

What is Pao Group’s dividend yield?

Pao Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services